These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23402972)

  • 1. Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine.
    Holmstock N; De Bruyn T; Bevernage J; Annaert P; Mols R; Tack J; Augustijns P
    Eur J Pharm Sci; 2013 Apr; 49(1):27-32. PubMed ID: 23402972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility profiling of HIV protease inhibitors in human intestinal fluids.
    Wuyts B; Brouwers J; Mols R; Tack J; Annaert P; Augustijns P
    J Pharm Sci; 2013 Oct; 102(10):3800-7. PubMed ID: 23939880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice.
    Holmstock N; Annaert P; Augustijns P
    Drug Metab Dispos; 2012 Aug; 40(8):1473-7. PubMed ID: 22550269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability.
    Stappaerts J; Wuyts B; Tack J; Annaert P; Augustijns P
    Eur J Pharm Sci; 2014 Oct; 63():178-86. PubMed ID: 25063035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.
    Markopoulos C; Thoenen F; Preisig D; Symillides M; Vertzoni M; Parrott N; Reppas C; Imanidis G
    Eur J Pharm Biopharm; 2014 Apr; 86(3):438-48. PubMed ID: 24184673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability.
    Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
    Int J Pharm; 2015 Jan; 478(2):736-44. PubMed ID: 25510602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
    Augustijns P; Wuyts B; Hens B; Annaert P; Butler J; Brouwers J
    Eur J Pharm Sci; 2014 Jun; 57():322-32. PubMed ID: 23994640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir.
    Aarnoutse RE; Wasmuth JC; Fätkenheuer G; Schneider K; Schmitz K; de Boo TM; Reiss P; Hekster YA; Burger DM; Rockstroh JK
    Antivir Ther; 2003 Aug; 8(4):309-14. PubMed ID: 14518700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of indinavir and the effect of food.
    Yeh KC; Deutsch PJ; Haddix H; Hesney M; Hoagland V; Ju WD; Justice SJ; Osborne B; Sterrett AT; Stone JA; Woolf E; Waldman S
    Antimicrob Agents Chemother; 1998 Feb; 42(2):332-8. PubMed ID: 9527781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorption.
    Holmstock N; Mols R; Annaert P; Augustijns P
    Drug Metab Dispos; 2010 Sep; 38(9):1407-10. PubMed ID: 20551242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.
    Riethorst D; Mitra A; Kesisoglou F; Xu W; Tack J; Brouwers J; Augustijns P
    Eur J Pharm Biopharm; 2018 Aug; 129():104-110. PubMed ID: 29802985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.
    Brouwers J; Tack J; Augustijns P
    Int J Pharm; 2007 May; 336(2):302-9. PubMed ID: 17207947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids.
    Persson EM; Gustafsson AS; Carlsson AS; Nilsson RG; Knutson L; Forsell P; Hanisch G; Lennernäs H; Abrahamsson B
    Pharm Res; 2005 Dec; 22(12):2141-51. PubMed ID: 16247711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An In-Depth View into Human Intestinal Fluid Colloids: Intersubject Variability in Relation to Composition.
    Riethorst D; Baatsen P; Remijn C; Mitra A; Tack J; Brouwers J; Augustijns P
    Mol Pharm; 2016 Oct; 13(10):3484-3493. PubMed ID: 27576295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
    Khoshakhlagh P; Johnson R; Langguth P; Nawroth T; Schmueser L; Hellmann N; Decker H; Szekely NK
    J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates.
    Ho YF; Lai MY; Yu HY; Huang DK; Hsueh WC; Tsai TH; Lin CC
    J Formos Med Assoc; 2008 Jan; 107(1):37-45. PubMed ID: 18218576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.